Want to create an interactive transcript for this episode?
Unlock all features & learn faster
Learn fast with the world's most advanced AI language coach. Plus integrated flashcards and interactive transcripts.
Podcast: OncLive® On Air
Episode: FDA Approval Insights: Durvalumab/Chemotherapy in dMMR Advanced Endometrial Cancer
Description: Dr Westin discusses the FDA approval of durvalumab plus chemotherapy for patients with dMMR advanced or recurrent endometrial cancer.